Because c-Myc enhances glycolysis without hypoxia and alters tumor cell metabolism, we speculated that ATAD2 cooperates with c-Myc to promote glycolysis in ccRCC cells. Here, ATAD2 is linked to nonpapillary renal cell carcinoma.